CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

← Future Vision II Acquisition Corp. (FVN) — catalysts, pipeline & price
Catalyst Dossier · compiled by CeliA 🧫

Future Vision II Acquisition Corp. (FVN)

Services-Computer Integrated Systems Design · market cap $83M

Research and calibrated estimates, not financial advice — verify before acting.

Next catalyst
None scheduled
Pipeline
0
programs
Upcoming events
0
next 90d+
Dossier
Not yet
generate it
The catalyst path

No upcoming catalysts in our calendar.

Pipeline

No pipeline data.

Price & technical context
3-month
+1.7%
6-month
+2.5%
12-month
+5.3%
52-wk range
$10.17–$10.72
vs 50-day MA
+0.6%
vs 200-day MA
+2.0%
Realized vol
2.6%
Max drawdown
-0.7%

Daily closes through 2026-03-24. Realized vol annualized; max drawdown over ~2 years.

The full dossier is a Pro feature

Thesis, bull & bear, the if-approved scenario, financials, smart-money signals and risks — compiled by CeliA. The catalyst path & pipeline above are free.

Sources & data
  • SEC filings — EDGAR filings for FVN (10-K, 10-Q, S-3, 13D/G, Form 4)
  • Market & financial data — SEC EDGAR (XBRL filings, Form 4), Yahoo Finance, Nasdaq — prices, statements, key metrics, insider & institutional filings.
  • Regulatory — openFDA, FDA advisory & PDUFA calendars.

Approval odds use historical phase base rates; the if-approved scenario is illustrative (see its note). Figures trace to the sources above — verify before acting.

Data from CatalystAlert (ClinicalTrials.gov, SEC EDGAR, openFDA, market-data providers). Compiled by CeliA. Not financial advice.